Find your next paid study

H. Lee Moffitt Cancer Center and Research InstituteNCT07725380

~$150 – $3,000

Actual pay is set by the research site.

Phase 1

ADEPT: Augmenting DBT Effectiveness With Psilocybin-Assisted Therapy

ADEPT is an open-label proof-of-concept study evaluating the safety and tolerability of psilocybin-assisted therapy in conjunction with Dialectical Behavior Th…

Borderline Personality DisorderBorderline Personality PathologyDepressive Symptoms+2 more

University of MinnesotaNCT07833761

~$150 – $3,000

Actual pay is set by the research site.

Tricuspid Regurgitation (TR)

Pivotal TRIal to Evaluate TraNsvenous TrIcuspid Valve ReplacemenT With Lux Valve Plus System in Patients With Severe or Greater Tricuspid Regurgitation - Clinical SafetY and Effectiveness

The goal of this clinical trial is to learn if LuX-Valve Plus system works to treat symptomatic subjects with at least severe tricuspid regurgitation (TR). It …

Jenscare Innovation Inc.NCT07454980

~$10 – $1,050

Actual pay is set by the research site.

Short-Course Antifungal Therapy vs Standard of Care (14 Day Therapy) for Uncomplicated Candidemia (SCAT)

The goal of this clinical trial is to assess whether a seven-day course of standard of care (echinocandin) antifungal therapy is non-inferior to a 14-day cours…

Candidemia

Augusta UniversityNCT06907992

Actual pay is set by the research site.

Phase 1

A Phase 1 Study to Evaluate TAG72-Targeting Chimeric Antigen Receptor (CAR) T Cells in Patients With Advanced Epithelial Ovarian Cancer

This phase I trial tests the safety, side effects, and best dose of TAG72-chimeric antigen receptor (CAR) T cells in treating patients with epithelial ovarian …

Platinum-Resistant Ovarian Carcinoma

City of Hope Medical CenterNCT05225363

~$150 – $3,000

Actual pay is set by the research site.

GlioblastomaNewly Diagnosed GlioblastomaBrain Tumor

REMIND: An Investigator Initiated Study Testing the Feasibility of Maintenance Radiotherapy for Patients With Newly Diagnosed Glioblastoma

REMIND is a single-center feasibility study testing maintenance radiotherapy in adult patients with newly diagnosed glioblastoma. Participants will be consent…

University of MinnesotaNCT07831772

Actual pay is set by the research site.

Phase 2

Pimavanserin for Insomnia in Veterans With Post-traumatic Stress Disorder

This is a preliminary randomized, double-blind, placebo-controlled trial comparing pimavanserin 34mg at bedtime vs. placebo for the treatment of insomnia assoc…

Post-traumatic Stress DisorderInsomnia

VA Office of Research and DevelopmentNCT05441280

~$75 – $1,800

Actual pay is set by the research site.

Phase 1

A Phase 1/2a Open-Label Study to Investigate the Safety of the Transplantation (by Injection) of Human Glial Restricted Progenitor Cells (hGRPs; Q-Cells®) Into Subjects With Transverse Myelitis (TM)

This study is a non-randomized, open-label, partially blinded, sequential cohort, dose-escalation study designed to obtain preliminary data on the safety, tole…

Transverse Myelitis

Q Therapeutics, Inc.NCT03887273

~$150 – $4,200

Actual pay is set by the research site.

Phase 2

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of VERVE-102, a One-Time Dose Gene Editing Medicine, in Adults With or at High Risk for Atherosclerotic Cardiovascular Disease (ASCVD) Who Require Additional Low-Density Lipoprotein-Cholesterol (LDL-C) Lowering

The purpose of this study is to measure the change in bad cholesterol (LDL-C) with VERVE-102 compared to placebo in adults who have plaque buildup in their art…

AtherosclerosisCardiovascular DiseaseHypercholesterolemia

Verve Therapeutics, Inc.NCT07839936

~$75 – $2,800

Actual pay is set by the research site.

Suicidal IdeationSuicide AttemptAnxiety+1 more

Recovery Through Inspiration, Support, and Empowerment

The goal of this pilot study is to test the effectiveness of a novel intervention for young adults (ages 18-27) with mental health conditions who have been rel…

University of Texas Southwestern Medical CenterNCT07051200

Actual pay is set by the research site.

Phase 2

A Phase II Study of Maintenance Zanzalintinib and Durvalumab in Patients With Advanced Hepatocellular Cancer After Induction Tremelimumab Plus Durvalumab

This research study is for people who were treated with tremelimumab and durvalumab for advanced liver cancer and who are currently receiving durvalumab. Parti…

Hepatocellular CarcinomaLiver Cancer

~$75 – $3,000

Actual pay is set by the research site.

Amit MahipalNCT07226063

Prebiotic Food-enriched Diet (PreFED) to Enhance the Microbiome and Response to First-line Immunotherapy in Unresectable Melanoma

To learn about the possible effects of a prebiotic food-enriched diet (PreFED) targeting the gut microbiome in participants with melanoma who are starting immu…

Unresectable Melanoma